Company

Vimian Group AB

Headquarters: Stockholm, Sweden

Employees: 600

CEO: Mr. Alireza Tajbakhsh

OMX: VIMIAN +3.46%

Detailed Description

Vimian Group AB (publ) engages in the animal health business worldwide. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets. It also provides procurement and tech-enabled services, such as preventive care plans, clinic improvement services, online marketing, and education, as well as a community for veterinary clinics through a membership-based platform; and orthopedic implants for veterinarians and universities. The company offers its services under the Nextmune, Indical Bioscience, VetFamily, and Movora brands. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Vimian Group AB has the following listings and related stock indices.


Stock: OMX: VIMIAN wb_incandescent

Stock: FSX: 0V0 wb_incandescent

Details

Headquarters:

Riddargatan 19

Stockholm, 114 57

Sweden

Phone: 46 7 09 66 71 76